Request Appointment
12902 USF Magnolia Dr.Tampa, FL 33612
Overview of Dr. Yun
Dr. Seongseok Yun is affiliated with H. Lee Moffitt Cancer Center and Research Institute. Dr. Yun received medical degree from Seoul National University College of Medicine, internal medicine residency training from University of Arizona, and clinical fellowship training in hematology and oncology at H. Lee Moffitt Cancer Center. Dr. Yun has been in practice 7 years. Dr. Yun specializes in malignant hematology.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2013 - 2016
Mayo Clinic College of MedicinePost-Doctoral Fellowship, 2009 - 2013
Seoul National University College of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2019 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CDA Award American Society of Clinical Oncology, 2022
- Miles for Moffitt Award Moffitt, 2022
- Scholar Award American Society of Hematology, 2020
- Join now to see all
Publications & Presentations
PubMed
- Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML).Zena Komrokji, Najla Al Ali, Zhuoer Xie, Onyee Chan, Seongseok Yun
Leukemia Research. 2025-03-01 - Hematological Response to Frontline Treatment in Lower Risk Myelodysplastic Syndromes (LRMDS) is Associated With Better Overall Survival.Rami S Komrokji, Muhammad Ammad-Ud-Din, Najla H Al Ali, Zhuoer Xie, Onyee Chan
Clinical Lymphoma, Myeloma & Leukemia. 2025-02-23 - RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, Hannah Newman, Ariel Quintana
Cancer Discovery. 2024-12-02
Grant Support
- MYC-alarmin axis as a novel therapeutic vulnerability in myelofibrosisH. LEE MOFFITT CANCER CTR & RES INST2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
